{"groups":[{"description":"All eligible subjects underwent up to 5 treatments at 4±1-week intervals to the vulva with a fractional CO2 laser and maintained protocol regimen.\n\nThe CO2RE® System: The CO2RE® system is a fractional CO2 laser that is FDA-cleared under a 510(k) K181523 for laser incision, excision, ablation and/or vaporization and of soft tissue in gynecology (GYN).","id":"FG000","title":"CO2RE® Treatment"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Lost to Follow-up"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"12","numUnits":"12"}],"type":"STARTED"},{"achievements":[{"comment":"2 subjects did not complete the final follow-up due to COVID-19 pandemic","groupId":"FG000","numSubjects":"10","numUnits":"10"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"2","numUnits":"2"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Although 14 subjects enrolled, 1 subject was withdrawn from the study due to a protocol violation and 1 subject was found to be not eligible prior to her first treatment. Therefore, 12 subjects are included in this analysis.","typeUnitsAnalyzed":"Treated areas"}